Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 1, 1997, Pages 301-309

  Jordan, James E ^a   Zhao, Zhi Qing ^a   Sato, Hiroki ^a   Taft, Spencer ^a   Vinten Johansen, Jakob ^a,b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Carlyle Fraser Heart Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2 RECEPTOR; SUPEROXIDE; ADENOSINE; ADENOSINE RECEPTOR; CREATINE KINASE; DRUG DERIVATIVE; PEROXIDASE; PHENETHYLAMINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOG; DRUG RECEPTOR BINDING; FEMALE; HEART MUSCLE ISCHEMIA; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; MALE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; ANIMAL; BLOOD; CELL ADHESION; CORONARY BLOOD VESSEL; DRUG EFFECT; HEART CONTRACTION; HEMODYNAMICS; METABOLISM; NEUTROPHIL; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ADENOSINE; ANIMALS; CELL ADHESION; CORONARY VESSELS; CREATINE KINASE; DOGS; ENDOTHELIUM, VASCULAR; FEMALE; HEMODYNAMIC PROCESSES; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; NEUTROPHILS; PEROXIDASE; PHENETHYLAMINES; RECEPTORS, PURINERGIC P1; SUPEROXIDES;

EID: 0030614436     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. ABEBE, W., MAKUJINA, S. R. AND MUSTAFA, S. J.: Adenosine receptor- mediated relaxation of porcine coronary artery in presence and absence of endothelium. Am. J. Physiol. 266: H201S-H2025, 1994.
2. 2 receptor agonist, CGS-21680, and nitroprusside in vascular smooth muscle. Eur. J. Pharmacol. 196: 117-123, 1991.
3. BECKER, L. C.: Do neutrophils contribute to myocardial stunning? Cardiovasc. Drugs Ther. 5: 909-913, 1991.
4. 2 receptors to inhibit neutrophil adhesion and injury to isolated cardiac myocytes. J. Immunol. 155: 2579-2586, 1995.
5. CHEN, L. Y., NICHOLS, W. W., HENDRICKS, J. B., YANG, B. C. AND MEHTA, J. L.: Monoclonal antibody to P-selectin (PB1.3) protects against myocardial reperfusion injury in the dog. Cardiovasc. Res. 28: 1414-1422, 1994.
6. 2 generation, respectively, J. Clin. Invest. 85: 1150-1157, 1990.
7. 2 receptors. J. Immunol. 148: 2201-2206, 1992.
8. 2 receptor on human neutrophils. J. Immunol. 135: 1366-1371, 1985.
9. DREYER, W. J., MICHAEL, L. H., WEST, M. W., SMITH, C. W., ROTHLEIN, R., ROSSEN, R. D., ANDERSON, D. C. AND ENTMAN, M. L.: Neutrophil accumulation in ischemic canine myocardium: Insights into time course, distribution, and mechanism of localization during early reperfusion. Circulation 84: 400-411, 1991.
10. ELY, S. W. AND BERNE, R. M.: Protective effects of adenosine in myocardial ischemia. Circulation 85: 893-904, 1992.
11. ENG, C., SANGHO, C., FACTOR, S. AND KIRK, E. S.: A nonflow basis for the vulnerability of the subendocardium. J. Am. Coll. Cardiol. 9: 374-379, 1987.
12. ENTMAN, M. L., MICHAEL, L., ROSSEN, R. D., DREYER, W. J., ANDERSON, D. C., TAYLOR, A. A. AND SMITH, C. W.: Inflammation in the course of early myocardial ischemia. FASEB J. 5: 2529-2537, 1991.
13. FORMAN, M. B., VIRMANI, R. AND PUETT, D. W.: Mechanisms and therapy of myocardial reperfusion injury. Circulation 81: suppl. IV, IV-69-IV-78, 1990.
14. GROSS, G. J. AND AUCHAMPACH, J. A.: Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ. Res. 70: 223-233, 1992.
15. GUNTHER, G. R. AND HERRING, M. B.: Inhibition of neutrophil Superoxide production by adenosine released from vascular endothelial cells. Ann. Vasc. Surg. 5: 325-330, 1991.
16. HORI, M., KITAKAZE, M., SATO, H., TAKASHIMA, S., IWAKURA, K., INOUE, M., KITABATAKE, A. AND KAMADA, T.: Staged reperfusion attenuates myocardial stunning in dogs: Role of transient acidosis during early reperfusion. Circulation 84: 2135-2145, 1991.
17. 2 selective adenosine receptor agonist with preferential hypotensive activity. J. Pharmacol. Exp. Ther. 251: 47-55, 1989.
18. KUBES, P.: Polymorphonuclear leukocyte-endothelium interactions: A role for pro-inflammatory and anti-inflammatory molecules. Can. J. Physiol. Pharmacol. 71: 88-97, 1993.
19. 1 receptor mechanism. Am. J. Physiol. 263: H1460-H1465, 1992.
20. LEFER, A. M.: Role of selectins in myocardial ischemia-reperfusion injury. Ann. Thorac. Surg. 60: 773-777, 1995.
21. LEFER, A. M., TSAO, P. S., LEFER, D. J. AND MA, X.: Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J. 5: 2029-2034, 1991.
22. LEFER, A. M., WEYRICH, A. S. AND BUERKE, M.: Role of selectins, a new family of adhesion molecules, in ischaemia-reperfusion injury. Cardiovasc, Res. 28: 289-294, 1994.
23. LEFER, D. J., NAKANISHI, K., JOHNSTON, W. E. AND VINTEN-JOHANSEN, J.: Antineutrophil and myocardial protection actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation 88: 2337-2350, 1993.
24. LUCCHESI, B. R.: Modulation of leukocyte-mediated myocardial reperfusion injury. Annu. Rev. Physiol. 52: 561-576, 1990.
25. LUCCHESI, B. R. AND MULLANE, K. M.: Leukocytes and ischemia-induced myocardial injury. Annu. Rev. Pharmacol. Toxicol. 26: 201-224, 1986.
26. MA, X., LEFER, D. J., LEFER, A. M. AND ROTHLEIN, R.: Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation 86: 937-946, 1992.
27. MEHTA, J. L., NICHOLS, W. W. AND MEHTA, P.: Neutrophils as potential participants in acute myocardial ischemia: Relevance to reperfusion. J. Am. Coll. Cardiol. 11: 1309-1316, 1988.
28. MILANE, K. M., KRAEMER, R. AND SMITH, B.: Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J. Pharmacol. Methods 14: 157-167, 1985.
29. 2-receptor agonists on myocardial reperfusion injury. Am. Heart J. 123: 332-338, 1992.
30. ROMSON, J. L., HOOK, B. G., KUNKEL, S. L., ABRAMS, G. D., SCHORK, M. A. AND LUCCHESI, B. R.: Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 67: 1016-1023, 1983.
31. SATO, H., ZHAO, Z.-Q., MCGEE, D. S., WILLIAMS, M. W., HAMMON, J. W., JR. AND VINTEN-JOHANSEN, J.: Supplemental L-arginine during cardioplegic arrest and reperfusion avoids regional postischemic injury. J. Thorac. Cardiovasc. Surg. 110: 302-314, 1995.
32. 2-receptor activation at reperfusion reduces infarct size and improves myocardial wall function in dog heart. J. Cardiovasc. Pharmacol. 22: 89-96, 1993.
33. SLUITER, W., PIETERSMA, A., LAMERS, J. M. J. AND KOSTER, J. F.: Leukocyte adhesion molecules on the vascular endothelium: Their role in the pathogenesis of cardiovascular disease and the mechanisms underlying their expression. J. Cardiovasc. Pharmacol. 22: suppl. 4, S37-S44, 1993.
34. SMITH, C. W., ENTMAN, M. L., LANE, C. L., BEAUDET, A. L., TY, T. I., YOUKER, K., HAWKINS, H. K. AND ANDERSON, D. C.: Adherence of neutrophils to canine cardiac myocytes in vitro is dependent on intercellular adhesion molecule-1. J. Clin. Invest. 88: 1216-1223, 1991.
35. STAHL, L. D., AVERSANO, T. R. AND BECKER, L. C.: Selective enhancement of function of stunned myocardium by increased flow. Circulation 74: 843-851, 1986.
36. TOOMBS, C. F., MCGEE, D. S., JOHNRTON, W. E. AND VINTEN-JOHANSEN, J.: Protection from ischaemic-reperfusion injury with adenosine pretreatment is reversed by inhibition of ATP-sensitive potassium channels. Cardiovasc. Res. 27: 623-629, 1993.
37. TSAO, P. S., AOKI, N., LEFER, D. J., JOHNSON, G., III AND LEFER, A. M.: Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation 82: 1402-1412, 1990.
38. TSAO, P. S. AND LEFER, A. M.: Time course and mechanism of endothelial dysfunction in isolated ischemic- and hypoxic-perfused rat hearts. Am. J. Physiol. 259: H1660-H1666, 1990.
39. VINTEN-JOHANSEN, J., LEFER, D. J., NAKANISHI, K., JOHNSTON, W. E., BRIAN, C. A. AND CORDELL, A. R.: Controlled coronary hydrodynamics at the time of reperfusion reduces postischemic injury. Coronary Artery Dis. 3: 1081-1093, 1992.
40. VINTEN-JOHANSEN, J., ZHAO, Z.-Q. AND SATO, H.: Reduction in surgical ischemic-reperfusion injury with adenosine and nitric oxide therapy. Ann. Thorac. Surg. 60: 852-857, 1995a.
41. VINTEN-JOHANSEN, J., ZHAO, Z.-Q., SATO, H., JORDAN, J. E., WILLIAMS, M. W. AND SARVOTHAM, S. S.: Reduction in infarct size but not neutrophil accumulation by controlled hydrodynamics of reperfusion. FASEB J. 9: A420, 1995b.
42. 2 receptor agonist. Cardiovasc. Drug Rev. 10: 26-53, 1992.
43. ZHAO, Z.-Q., MCGEE, D. S., NAKANISHI, K., TOOMBS, C. F., JOHNSTON, W. E., ASHAR, M. S. AND VINTEN-JOHANSEN, J.: Receptor-mediated cardioprotective effects of endogenous adenosine are exerted primarily during reperfusion after coronary occlusion in the rabbit. Circulation 88: 709-719, 1993.
44. 1-receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischaemia. Cardiovasc. Res. 28: 270-279, 1994a.
45. 2-receptor activation inhibits neutrophil-mediated injury to coronary endothelium by attenuating Superoxide anion generation and adherence. Circulation 90: suppl., I-372, 1994b.
46. 2-receptor activation inhibits neutrophil-mediated injury to coronary endothelium. Am. J. Physiol., 271: H1456-H1464, 1996.
47. ATP-channel activation, Circulation 92: I-525, 1995.